The rapid microbiology testing market is projected to grow from USD 5.5 billion in 2025 to USD 13.4 billion by 2035, at a CAGR of 9.4%. Reagents and Kits will dominate with a 46.8% market share, while nucleic acid-based rapid microbiology testing will lead the method segment with a 39.5% share.